Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy

BACKGROUND: The development of a safe and effective AD vaccine requires a delicate balance between providing an adequate anti-Aβ antibody response sufficient to provide therapeutic benefit, while eliminating an adverse T cell-mediated proinflammatory autoimmune response. To achieve this goal we have...

Descripción completa

Detalles Bibliográficos
Autores principales: Movsesyan, Nina, Ghochikyan, Anahit, Mkrtichyan, Mikayel, Petrushina, Irina, Davtyan, Hayk, Olkhanud, Purevdorj B., Head, Elizabeth, Biragyn, Arya, Cribbs, David H., Agadjanyan, Michael G.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2358976/
https://www.ncbi.nlm.nih.gov/pubmed/18461171
http://dx.doi.org/10.1371/journal.pone.0002124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2358976/
https://www.ncbi.nlm.nih.gov/pubmed/18461171
http://dx.doi.org/10.1371/journal.pone.0002124

Ejemplares similares